Skip to main content
Fig. 4 | BMC Geriatrics

Fig. 4

From: Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility study

Fig. 4

Adherence to the Atrial Fibrillation Better Care pathway and pharmacist recommendations in the event of non-adherence. AF, atrial fibrillation; ACEI, angiotensin converting enzyme inhibitor; AKI, acute kidney injury; BB, beta-blocker; BP, blood pressure; EHRA, European Heart Rhythm Association; ESRD, end stage renal disease; GI, gastrointestinal; HbA1c, glycated haemoglobin; HFpEF, heart failure with preserved ejection fraction (≥ 50%); HFrEF, heart failure with reduced ejection fraction (< 40%); HR, heart rate; LFTs, liver function tests; NOAC, non-vitamin K antagonist oral anticoagulant; OAC, oral anticoagulant; TTR, time in therapeutic range; VKA, vitamin K antagonist

Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us